资讯

Novo Nordisk focused on biotech deals for cardiometabolic indications
In the aftermath of several deals with smaller biotechs made in the 13 months in the cardiometabolic space, Novo Nordisk has ...
AbTherx and GPCR Therapeutics Announce a Strategic Collaboration to Discover Novel Antibody ...
Partnership combines AbTherx's proprietary Atlas™ Long CDR3 Technology with GPCR Therapeutics' deep expertise in GPCR biology to discover and develop antibodies for novel targets MOUNTAIN VIEW, CA / ...